[Perspectives in pediatric renal transplantation].

Nephrol Ther

Clinique Médicale Pédiatrique, Hôpital Mère Enfant, 7 Quai Moncousu, 44093 Nantes cedex, France.

Published: December 2011

New immunosuppressive drugs are administered in adults after renal transplantation to prevent toxicities (nephrotoxicity, cardiovascular complications…). Among these, Belatacept exhibited exciting results and its indication in pediatric patients will have to be validated, especially in EBVpositive recipients. Rituximab, bortezomide and eculizumab are also currently being evaluated in protocols of desensitization and in the treatment of humoral rejections. An individually tailored immunosuppressive regimen might be considered in the future, based on the study of certain polymorphisms or on immune status and alloreactivity determined by new biomarkers. Finally, the development of EBV and cmV vaccines would prevent these infections after transplantation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nephro.2011.11.008DOI Listing

Publication Analysis

Top Keywords

[perspectives pediatric
4
pediatric renal
4
renal transplantation]
4
transplantation] immunosuppressive
4
immunosuppressive drugs
4
drugs administered
4
administered adults
4
adults renal
4
renal transplantation
4
transplantation prevent
4

Similar Publications

Purpose: This study aims to explore the demographic, clinical, and psychological factors that influence the quality of life in children with chronic illnesses.

Design And Methods: A descriptive, cross-sectional study was conducted between February and July 2023. The sample consisted of 120 pediatric patients, aged 7 to 18 years, diagnosed with chronic illnesses and treated in outpatient and inpatient wards.

View Article and Find Full Text PDF

Eczema is also known as atopic dermatitis, which goes on to affect the skin as a chronic inflammatory disease. It is associated with a constant feeling of scratchiness, erthyma and disruption of the natural skin barrier. Treatment provided at present may improve some of the symptoms, for instance use of corticosteroids or immunosuppressive agents, however, there is an overwhelming need for better focused and effective methods of treatment with minimal adverse effects.

View Article and Find Full Text PDF

Background: Methylmalonic acidemia (MMA), type mut (0) is a rare type of genetic inborn error of metabolism (IEM) that is caused by aberrant malonyl-CoA mutase activity. Diagnosing IEM can be challenging due to its inherited onset and varying degrees of severity.

Methods And Results: In the present study, a consanguineous Pakistani family suspected of IEM was genetically analyzed using whole exome sequencing.

View Article and Find Full Text PDF

Introduction: The transition from paediatric to adult health care (i.e., 'health care transition') poses many challenges for youth with medical complexity (YMC) and their families.

View Article and Find Full Text PDF

Global strategies for preventing type 2 diabetes: A public health perspective.

Indian J Med Res

November 2024

Department of Pediatrics, University of Alabama at Birmingham, Division of Pediatric Endocrinology and Diabetes, Alabama, 35233, United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!